|Application:||Gene expression microarray analysis|
|Number of samples:||275|
|Release date:||Jun 28 2013|
|Last update date:||Sep 9 2014|
|Diseases:||Breast Neoplasms, Neoplasms, Dystonic Disorders|
|Dataset link||Classifications within Molecular Subtypes Enables Identification of BRCA1/BRCA2 Mutation Carriers by RNA Tumor Profiling|
Gene expression profiling of 183 breast tumor samples. Breast tumors from hereditary breast cancer patients carrying a pathogenic BRCA1 (n=33) or BRCA2 (n=22) germ-line mutation were included in the study. Serving as a representative control group, primary breast tumor samples (n=128) were randomly selected. The study was conducted using Agilent-029949 Custom SurePrint G3 Human GE 8x60K Microarray platform. For cross-platform validation, a subset of the tumor samples (92 of the 183 samples) were analyzed by our in-house spotted microarray platform.
Martin Jakob Larsen